| Literature DB >> 35562822 |
Takeya Kitta1, Hirokazu Abe2, Huang Ting-Wen3, Masahiro Fujikawa2, Minoru Nakazono2, Taiki Sasa2, Yukiko Doi2, Sari Toki2, Daigo Okada2, Atsuhiko Ochi2, Koichiro Suzuki2, Yasuhide Kitagawa4, Nobuo Shinohara5.
Abstract
BACKGROUND: It has been hypothesized that women with significant pelvic organ prolapse (POP), particularly of the anterior vaginal wall, may have voiding dysfunction (VD). Although the VD mechanism due to cystocele is not fully understood, different vaginal compartments have rarely been closely examined. This study attempted to further elucidate the correlation between POP and VD through a new subgroup classification using cystoscopy.Entities:
Keywords: Anterior wall prolapse; Cystoscopy; Pelvic organ prolapse; Quality of life; Voiding dysfunction
Mesh:
Year: 2022 PMID: 35562822 PMCID: PMC9102938 DOI: 10.1186/s12905-022-01747-5
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Fig. 1Bladder examination using cystoscopy was performed in the lithotomy position at rest and under the Valsalva maneuver. Dotted line: interuretieric crest. Arrow: hernia orifice
Fig. 2a The subjects were divided into four groups according to the presence of hernia orifice by cystoscopy: trigone type, posterior wall type, trigone and urethra type, and trigone and posterior wall type. Dotted line: interuretieric crest. Arrow: hernia orifice. b Schematic of four groups according to the presence of hernia orifice by cystoscopy: trigone type, posterior wall type, trigone and urethra type, and trigone and posterior wall type
Population characteristics
| Characteristics | All patients | Trigone type | Posterior wall type | Trigone and urethra type | Trigone and posterior wall type |
|---|---|---|---|---|---|
| Number | 49 | 7 | 10 | 13 | 19 |
| Age (years) | 72 (50–91) | 73 (70–81) | 71 (61–81) | 71 (50–85) | 73 (59–91) |
| BMI (kg/m2) | 24.0 ± 3.4 | 24.5 ± 1.5 | 24.5 ± 3.2 | 23.9 ± 3.4 | 23.7 ± 4.0 |
| Parity (median (range)) | 2 (0–5) | 3 (0–3) | 2 (2–3) | 2 (2–3) | 2 (1–4) |
| POP-Q stage III, IV | 42, 7 | 7, 0 | 10, 0 | 12, 1 | 13, 6 |
Data are mean ± standard deviation or n (range)
BMI body mass index, POP-Q pelvic organ prolapse quantification
Preoperative pelvic organ prolapse quantification (POP-Q)
| POP‐Q point | Trigone type | Posterior wall type | Trigone and urethra type | Trigone and posterior wall type | ||
|---|---|---|---|---|---|---|
| Aa | 2.6 ± 1.1 | 2.1 ± 1.3 | 1.8 ± 1.5 | 1.5 ± 1.4 | 0.39 | |
| Ba | 4.0 ± 1.3 | 4.1 ± 0.9 | 2.8 ± 1.4 | 3.7 ± 2.8 | 0.40 | |
| C | 2.9 ± 2.4 | 2.4 ± 2.2 | 1.2 ± 2.4 | 2.9 ± 3.4 | 0.43 | |
| Gh | 4.9 ± 0.8 | 3.6 ± 0.5 | 3.9 ± 0.7 | 4.1 ± 1.0 | 0.03* | T vs. |
| Pb | 2.5 ± 0.5 | 3.0 ± 0.2 | 2.9 ± 0.4 | 2.9 ± 0.3 | 0.09 | |
| TVL | 6.7 ± 3.6 | 7.8 ± 0.4 | 8.4 ± 1.1 | 8.1 ± 0.9 | 0.19 | |
| Ap | − 0.4 ± 1.7 | − 0.9 ± 1.5 | − 1.4 ± 1.3 | − 0.9 ± 2.0 | 0.70 | |
| Bp | 0.1 ± 1.4 | 0.7 ± 1.7 | − 0.8 ± 2.4 | 1.5 ± 3.4 | 0.17 | |
| D | − 2.1 ± 1.2 | − 1.1 ± 2.5 | − 3.1 ± 3.3 | − 0.5 ± 4.4 | 0.24 |
Data are mean ± standard deviation
T trigone type, P posterior wall type, * < 0.05
Lower urinary tract function of four groups
| Characteristics | Trigone type | Posterior wall type | Trigone and urethra type | Trigone and posterior wall type | ||
|---|---|---|---|---|---|---|
| Voided volume | 275.4 ± 127.8 | 255.0 ± 171.4 | 395.8 ± 114.9 | 356.8 ± 118.7 | 0.07 | |
| Postvoid residual urine volume | 116.6 ± 104.0 | 150.0 ± 133.2 | 39.8 ± 113.7 | 22.4 ± 48.4 | 0.01* | |
| Maximal urinary flow rates | 16.7 ± 7.6 | 14.9 ± 11.2 | 25.5 ± 10.9 | 23.1 ± 11.0 | 0.27 | |
| Average urine flow rate | 8.8 ± 3.7 | 7.9 ± 5.8 | 15.7 ± 6.6 | 11.5 ± 5.8 | 0.02* |
Data are mean ± standard deviation
P posterior wall type, T&P trigone and posterior wall type, T&U trigone and urethra type, * < 0.05
PFDI-20 and ICIQ-SF score of four groups
| Variables | Trigone type | Posterior wall type | Trigone and urethra type | Trigone and posterior wall type | |
|---|---|---|---|---|---|
| PFDI-20 | |||||
| POPDI | 11.2 ± 8.6 | 14.0 ± 5.1 | 11.2 ± 6.1 | 8.5 ± 8.0 | 0.38 |
| CRADI | 5.0 ± 6.2 | 8.4 ± 6.4 | 4.2 ± 5.1 | 4.2 ± 4.3 | 0.31 |
| UDI | 10.2 ± 5.4 | 11.7 ± 5.7 | 4.2 ± 4.3 | 7.1 ± 6.2 | 0.37 |
| Total | 26.3 ± 14.9 | 32.6 ± 14.6 | 25.5 ± 14.2 | 22.8 ± 15.4 | 0.56 |
| ICIQ-SF | |||||
| Q1 | 2.8 ± 1.6 | 1.9 ± 1.6 | 0.9 ± 1.1 | 1.5 ± 1.5 | 0.10 |
| Q2 | 1.6 ± 0.8 | 1.8 ± 1.5 | 1.2 ± 1.0 | 1.3 ± 1.2 | 0.69 |
| Q3 | 1.0 ± 1.6 | 3.3 ± 2.8 | 2.3 ± 2.1 | 3.2 ± 3.5 | 0.44 |
| Total | 5.4 ± 0.5 | 7.0 ± 5.6 | 4.4 ± 3.7 | 5.9 ± 5.7 | 0.69 |
Scores of the PFDI-20 and ICIQ-SF score of four groups (n = 49)
PFDI-20 pelvic floor distress inventory short form, ICIQ-SF international consultation of incontinence questionnaire-short form. The PFDI score is the total of the Pelvic Organ Prolapse Distress Inventory (POPDI) score (bulging), Colorectal-Anal Distress Inventory (CRADI) score (defecation), and Urinary Distress Inventory (UDI) score (micturition). The ICIQ-SF is comprised of three questions regarding frequency, severity and QoL impact of the urinary incontinence. Data are mean ± standard deviation